(Q44888769)

English

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

based on heuristic

inferred from title

author name string

Gregory S Merrick

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Wayne M Butler

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Robert W Galbreath

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Jonathan H Lief

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Edward Adamovich

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

98-103

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Should Gleason score 7 prostate cancer be considered a unique grade category?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Palladium-103 brachytherapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome and predictive factors for patients with Gleason score 7 prostate carcinoma treated with three-dimensional conformal external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of seed loading approaches in prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential role of various dosimetric quality indicators in prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Seed fixity in the prostate/periprostatic region following brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isotope selection for patients undergoing prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(02)01640-0

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44888769&oldid=2055810936"